Navigation Links
ConvaTec Presents New Data on ConvaTec Moldable Technology™ and Vitala™ Continence Control Device in Ostomy Care
Date:6/7/2011

SKILLMAN, N.J., June 7, 2011 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today presented new data from multiple studies related to its advanced technologies in ostomy care including ConvaTec Moldable Technology™ and the Vitala™ Continence Control Device (CCD).  Results were presented at the Wound, Ostomy and Continence Nurses Society (WOCN) 43rd Annual Conference held June 4-8, 2011 in New Orleans, LA.

ConvaTec Moldable Technology™ Skin Barriers ConvaTec Moldable Technology™ Skin Barriers with Rebounding Memory Technology™ are the only skin barriers with a patented* tri-laminate construction that actively adjusts to the shape and contours of the stoma. ConvaTec Moldable Technology™ Skin Barriers are also backed by extensive clinical experience demonstrating their ability to prevent leaks and protect the peristomal skin.(1,2)  ConvaTec presented five abstracts on patient and heath care provider experiences with Moldable Technology™:  

  • A Survey of Quality of Life Measures in Patients Who Have Transitioned from Using a Non-Moldable Skin Barrier to a Moldable Skin Barrier (Abstract # 5452)

  • Skin Barrier Selection in an Outpatient Ostomy Clinic (Abstract # 5250)

  • The Perfect Fit: Moldable Technology in Home Care (Abstract # 5217)

  • The Road to Independence: Successful Use of Moldable Ostomy Skin Barriers to Improve Patient Outcomes (Abstract # 5137)

  • Use of a Moldable Skin Barrier with Adhesive Coupling to Manage Severely Denuded Peristomal Skin (Abstract # 5251)

  • Vitala™ Continence Control Device (CCD)Data was also presented data on the Vitala™ CCD, an innovative, non-invasive device that restores continence for up to 12 hours per day, allowing patients to manage their colostomy without having to wear a pouch or incorporate irrigation. The unique design also helps to reduce odor and noise.(3) Four prospective case studies of patient experiences with Vitala™ CCD drawn from the device's Phase 3 clinical trial(4) were presented as an abstract and poster titled:  

  • Patient and WOC Nurse Assessment of a Novel Continence Control Device (CCD): Stoma Management, Quality of Life and Productivity (Abstract # 5154)

  • "For more than 30 years, ConvaTec has been committed to meeting the needs of people living with an ostomy through breakthrough solutions in medical technology. Each of our products is developed based on health care provider and patient feedback in order to provide genuine benefits to patients and their health care teams. Our focus is on advancing technologies that can offer unparalleled security and ease of use to empower patients in their recovery from this life-changing surgery," said Brad Barton, President, ConvaTec USA.

    Vitala™ CCD is currently available in the Netherlands, Czech Republic and United Kingdom, and is soon to be launched in additional European markets.

    About ConvaTecConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.

    ConvaTec Moldable Technology, Rebounded Memory Technology and Vitala are registered trademarks of ConvaTec Inc. * U.S. Patent No. 6,840,924 B2© 2011 ConvaTec Inc.

    SC-000245-USContactsPunnie DonohueAndrea CoanConvaTec

    Berry & Company Public Relations908-904-2151

    212-253-8881Punnie.donohue@convatec.com

    acoan@berrypr.com(1) Scott V, Raasch D, Kennedy G, Heise C. Prospective assessment and classification of stoma related skin disorders. Poster presented at: 41st Annual Wound Ostomy and Continence Nurses Society Conference; June 6-10, 2009; Orlando, Florida(2) Hoeflok J, Guy D, Allen S, St-Cry D. A prospective multicenter evaluation of a moldable stoma skin barrier. Ostomy Wound Manage. 2009;55(5):62-69.(3) Multinational Phase III Vitala™ CCD 12-Hour Wear Test. CC-0196-08-A720. June 18, 2010, Data on file, ConvaTec Inc.(4) CC 0196-10-A725 Final Study Report
    '/>"/>

    SOURCE ConvaTec
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. New Data Supports ConvaTec Negative Pressure Wound Therapy
    2. ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing
    3. ConvaTec to Present at AdvaMed 2010: The MedTech Conference
    4. Bradford Barton Named President, ConvaTec U.S.
    5. ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering
    6. ConvaTec Announces New Appointments to Leadership Team
    7. ConvaTec Announces New Appointment to Leadership Team
    8. ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans
    9. ConvaTec Healthcare Postpones Plans To Refinance Secured Term Loans
    10. Holy Family Medical Center Selects ConvaTec Negative Pressure for Wound Care
    11. ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/8/2016)... -- Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices Market Outlook to 2022", provides ... Devices market. The report provides value, in millions ... prices (USD) within market segement - Glaucoma Drainage ... and distribution shares data for each of these ...
    (Date:12/8/2016)... 2016 KEY FINDINGS The global ... 2017-2023. Various reasons for growth of the medical lifting ... of chronic diseases, high recovery cost of injuries and ... Medical lifting sling refers to an assistive device that ... slings connect to the lift and hold the patient. ...
    (Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
    Breaking Medicine Technology:
    (Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
    (Date:12/9/2016)... NY (PRWEB) , ... December 09, 2016 , ... ... and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... and the District of Columbia as an education tool in the war against teen ...
    (Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted ... all types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves ... use and could be set up in a matter of minutes, or even seconds. ...
    (Date:12/9/2016)... ... 09, 2016 , ... The Holy Name Medical Center Foundation ... on December 3rd, to benefit Holy Name Medical Center's programs and services. More ... over $1 million - the largest event in the Center's history, both in ...
    (Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to get ... thought that if the nebulizer had a more child-friendly design, then children would be ... developed the patent-pending NEBY to avoid the need to deliver medication via a nebulizer ...
    Breaking Medicine News(10 mins):